Tenet Healthcare (NYSE:THC) Director Nadja West Sells 1,152 Shares

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 1,152 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the sale, the director directly owned 23,653 shares of the company’s stock, valued at $6,121,396.40. This represents a 4.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tenet Healthcare Stock Up 2.0%

Tenet Healthcare stock traded up $5.11 during trading on Thursday, hitting $263.64. 870,331 shares of the company were exchanged, compared to its average volume of 742,344. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The business’s 50 day moving average is $236.52 and its 200 day moving average is $210.85. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05. The company has a market capitalization of $21.23 billion, a P/E ratio of 10.17, a PEG ratio of 0.99 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in THC. California State Teachers Retirement System raised its holdings in Tenet Healthcare by 18,362.2% in the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock worth $3,533,142,000 after purchasing an additional 18,783,432 shares in the last quarter. Norges Bank purchased a new stake in shares of Tenet Healthcare in the 4th quarter worth about $248,494,000. Wellington Management Group LLP lifted its position in Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock valued at $225,706,000 after acquiring an additional 1,042,260 shares during the period. Manning & Napier Advisors LLC purchased a new stake in Tenet Healthcare in the second quarter worth about $168,761,000. Finally, Boston Partners increased its stake in shares of Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

THC has been the topic of several recent research reports. Zacks Research upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Guggenheim raised their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. Morgan Stanley upped their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday, July 27th. Finally, Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Buy” and a consensus price target of $273.00.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.